DongKoo Bio&Pharma Co. Ltd (006620) — Long-term Investment Intensity
DongKoo Bio&Pharma Co. Ltd (006620) has a Long-term Investment Intensity of 2.3% as of December 2017. Long-term investments of ₩1.76 Billion represent 2.3% of total assets of ₩75.59 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check DongKoo Bio&Pharma Co. Ltd (006620) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
DongKoo Bio&Pharma Co. Ltd Long-term Investment Intensity (2015–2017)
This chart shows how DongKoo Bio&Pharma Co. Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2017. As of December 2017, the intensity stands at 2.3%, reflecting long-term investments of ₩1.76 Billion against total assets of ₩75.59 Billion KRW. Explore 006620 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for DongKoo Bio&Pharma Co. Ltd (2015–2017)
The table below presents the year-by-year Long-term Investment Intensity for DongKoo Bio&Pharma Co. Ltd from 2015 to 2017, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 006620 company net worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 2.3% | ₩1.76 Billion | ₩75.59 Billion | ▼ -1.0 pp |
| 2016 | 3.3% | ₩2.18 Billion | ₩65.31 Billion | ▼ -1.3 pp |
| 2015 | 4.6% | ₩2.82 Billion | ₩60.77 Billion | — |